Abbott warns: Apple iOS 17 may affect blood glucose monitoring devices

News on September 22, global medical device giant ABBOTT recently issued a notice recommending the use of its FreeStyle Libre Apple iPhone users of 3rd and other products should not upgrade to iOS 17 for the time being and turn off the automatic update function to ensure the normal operation of the device.

According to a notice issued by Abbott, the StandBy mode and Assistive Access mode of iOS 17 may affect FreeStyle Libre 3's core functionality is negatively affected. These core features include alerting users if their blood sugar levels are low or high, and the availability of an alert system. Abbott has pledged to FreeStyle Libre 3 users sent emails alerting them to the matter and strongly recommending to disable automatic operating system updates on their smartphones.

According to the editor's understanding, if the user fails to take action or fails to use the device in accordance with the instructions in the device label, serious hypotension may result. Blood glucose or hyperglycemic events are missed, potentially affecting treatment decisions. Therefore, in order to ensure the health and safety of users, Abbott recommends that users be sure to check the compatibility guide on the official website before upgrading the iOS system to avoid problems. Users should pay close attention to Abbott's official notification for information on when it is safe to upgrade to iOS 17 or take other measures for the latest information. In addition, users should follow the medical device's instructions for use and consult a physician when needed to ensure that their blood sugar management is effectively monitored and maintained.

The above is the detailed content of Abbott warns: Apple iOS 17 may affect blood glucose monitoring devices. For more information, please follow other related articles on the PHP Chinese website!